This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
European Journal of Heart Failure
JANUARY 17, 2025
A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end-organ dysfunction.
American College of Cardiology
MARCH 30, 2025
Implantation of an intra-aortic balloon pump (IABP) did not improve 60-day survival or bridge to heart replacement (HRT) therapies in patients with heart failure-cardiogenic shock (HF-CS) compared to standard care, according to a study presented during a Featured Clinical Research session at ACC.25
Frontiers in Cardiovascular Medicine
JANUARY 28, 2025
Care for survivors after an acute attack of COVID-19 should include paying close attention to cardiovascular health and disease.Systematic Review RegistrationPROSPERO [CRD42022353965].
95 
CardiacWire
SEPTEMBER 25, 2024
Windtree Therapeutics’ istaroxime appears to have scored in its latest Phase 2b trial , showing that the steroidal drug significantly improves systolic blood pressure in cardiogenic shock patients. That could be a big deal in the cardiogenic shock space, which many believe is still in need of more effective treatments.
American College of Cardiology
FEBRUARY 1, 2024
What are the characteristics and outcomes of cardiogenic shock (CS) in children hospitalized for acute decompensated heart failure (ADHF)?
ECG Cases
JANUARY 4, 2022
What is the preferred order of vasopressors and ionotropes in the management of cardiogenic shock? How can we best pick up occult cardiogenic shock before it floured shock kicks in? Which patients with acute heart are safe to send home in general?
DAIC
DECEMBER 18, 2024
12, 2024 Physicians have a new treatment option for many of the sickest pediatric patients with heart failure andcardiogenic shock. and Impella CP enable heart recovery as part of the world's smallest heart pump platform. with SmartAssist tim.hodson Wed, 12/18/2024 - 14:06 Dec.
52 
Circulation: Heart Failure
JULY 9, 2024
Circulation: Heart Failure, Ahead of Print.
Circulation: Heart Failure
JANUARY 20, 2025
Circulation: Heart Failure, Ahead of Print. The integrative physiology of the left ventricle and systemic circulation is fundamental to our understanding of advanced heart failure and cardiogenic shock. Importantly, we outline 4 key components for a more complete assessment of vascular afterload.
Frontiers in Cardiovascular Medicine
JANUARY 3, 2024
Although the contemporary shock stages classification provided a standardized shock severity assessment, individual agents or management strategy has not yet been studied in the context of each shock stage. The pre-shock state may comprise a wide range of presentations.
Circulation
NOVEMBER 11, 2024
Cardiogenic shock rates were highest among SV-CHD patients, with significant fluctuations, followed by DV-CHD patients. Variations in cardiogenic shock, MCS usage, and cardiac transplants emphasize the need for adaptive clinical practices to optimize patient outcomes. Patients without CHD were older (mean age 71.5
Frontiers in Cardiovascular Medicine
FEBRUARY 24, 2025
Despite initiating thrombolysis for cerebral infarction and supportive treatments for heart failure, including VA-ECMO, the patient's condition continued to decline, evidenced by cardiogenic shock, heart failure, and progressive neurological deficits including coma and dilated non-reactive pupils.
Circulation: Heart Failure
MARCH 28, 2025
Circulation: Heart Failure, Ahead of Print. Cardiogenic shock (CS) remains a significant challenge in cardiovascular medicine, characterized by substantial morbidity and mortality.
European Journal of Heart Failure
NOVEMBER 23, 2023
Clinical presentation, shock severity and mortality in patients with de novo versus acute-on-chronic heart failure-related cardiogenic shock. ACHF-CS, acute-on-chronic failure-related cardiogenic shock; CI, confidence interval; DNHF-CS, de novo heart failure-related cardiogenic shock; HR, hazard ratio.
JAMA Cardiology
OCTOBER 26, 2024
In a seminal case series published in 1967, Killip and Kimball reported 81% in-hospital mortality for patients presenting with acute myocardial infarction complicated by cardiogenic shock (AMI-CS).
Science Daily - Heart Disease
AUGUST 30, 2023
The hope is that these systems will improve survival after the most severe form of acute heart failure, cardiogenic shock. A recent clinical trial has shown that extracorporeal life support (ECLS) does not reduce 30-day mortality after cardiogenic shock.
American College of Cardiology
MARCH 31, 2025
The goal of the Altshock-2 trial was to evaluate the effect of early intra-aortic balloon pump (IABP) use vs. standard care on 60-day survival or successful bridging to heart replacement therapies (HRT) in patients with heart failurecardiogenic shock (HF-CS).
European Journal of Heart Failure
DECEMBER 11, 2024
Abstract Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.
European Journal of Heart Failure
DECEMBER 19, 2024
Ventilatory modalities in cardiogenic shock: insights from the AltShock-2 registry. Aims To describe the use and the relation to outcome of different ventilation strategies in a contemporary, large, prospective registry of cardiogenic shock patients.
Journal of the American Heart Association
FEBRUARY 26, 2025
BackgroundCardiogenic shock carries high mortality. male, 67% acute myocardial infarction, 33% acute decompensated heart failure), 45 (41.3%), 33 (30.3%), and 31 (28.4%) were in SCAI Shock Stages C, D, and E, respectively. A suggestive trend of improving 30day survival was observed (56.8%, 63.9%, and 72.2%
Frontiers in Cardiovascular Medicine
MAY 6, 2024
Multiple clinical manifestations have been reported, including acute heart failure, cardiogenic shock, and ventricular arrhythmias. We present three patients with clinically suspected viral myocarditis causing acute heart failure. Viral myocarditis is an important cause of non-ischemic cardiomyopathy.
European Journal of Heart Failure
DECEMBER 13, 2023
Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardial infarction-related cardiogenic shock (AMICS). Methods and results This nationwide observational cohort study describes all AMICS patients treated with Impella (ABIOMED, Danvers, MA, USA) and/or VA-ECMO in 2020–2021.
Circulation: Heart Failure
FEBRUARY 29, 2024
Circulation: Heart Failure, Ahead of Print.
Journal of Cardiothoracic Surgery
AUGUST 23, 2024
Fulminant myocarditis has been defined as the clinical manifestation of cardiac inflammation with rapid-onset heart failure and cardiogenic shock. We report on the case of a 17-year-old boy with hemodynamic de.
Frontiers in Cardiovascular Medicine
MARCH 27, 2024
Additionally, acute heart failure (AHF) can occur in up to 40% of cases, and its presence can impact the clinical outcomes of patients with IE. Cardiogenic shock (CGS) is often more likely to occur after AHF has taken place. If bacteria invade the blood, infectious shock can occur.
Circulation: Heart Failure
DECEMBER 6, 2023
Circulation: Heart Failure, Ahead of Print.
Circulation: Heart Failure
APRIL 14, 2025
Circulation: Heart Failure, Ahead of Print.
Circulation
NOVEMBER 11, 2024
Background:Various temporary mechanical circulatory support device (t-MCS) options are available for supporting patients in cardiogenic shock. While each device has a different physiological impact on the heart, limited studies compare genetic changes in the heart t-MCS. and 4 bridged with IABP.
European Journal of Heart Failure
MARCH 19, 2025
Abstract Patients presenting with or alerting emergency networks due to acute heart failure (AHF) form a diverse group with a plethora of symptoms, risks, comorbidities, and aetiologies. Scientific guidelines provide clear recommendations for the management of arrhythmias in chronic heart failure patients.
Circulation: Heart Failure
MARCH 8, 2024
Circulation: Heart Failure, Ahead of Print. A secondary analysis evaluated outcomes for severe HF hospitalizations (cardiogenic shock, cardiac arrest, and mechanical ventilation). of centers), 525 037 (18.3%) were admissions to ATCs (5.5% of centers), and 15 541 (0.5%) were transferred to ATCs.
Circulation: Heart Failure
JANUARY 20, 2025
Circulation: Heart Failure, Ahead of Print.
Circulation
NOVEMBER 11, 2024
As heart failure with preserved ejection fraction (HFpEF) comprises half of all heart failure cases, understanding its management and effect on outcomes is crucial. There was a non-significant increased risk of cardiogenic shock (aOR 1.14, 95% CI 0.87 - 1.5,
The American Journal of Cardiology
OCTOBER 5, 2024
Publication date: Available online 5 October 2024 Source: The American Journal of Cardiology Author(s): Meghana Iyer, Khaled Ziada, Leslie Cho, Jacqueline Tamis-Holland, Umesh Khot, Amar Krishnaswamy, Rishi Puri, Samir Kapadia, Grant W Reed
Journal of Cardiothoracic Surgery
DECEMBER 29, 2024
Veno-arterial (V-A) extracorporeal membrane oxygenation (ECMO) is commonly used for patients with cardiac arrest, cardiogenic shock, or heart failure and is a life-saving technique. Computed tomography angiogr.
Circulation
NOVEMBER 11, 2024
A 35-year-old gravida 1, para 0 with biventricular heart failure (LVEF 25%), nonischemic cardiomyopathy, history stroke, history of left ventricular thrombus, class III obesity, and chronic kidney disease who had been followed by Cardio-Obstetrics throughout her pregnancy presented at 34 weeks gestation for planned induction of labor.
Circulation
NOVEMBER 11, 2024
The understanding of mechanisms of recovery with t-MCS’s could facilitate the modulation of specific pathways to promote recovery. and 4 bridged with IABP. and 4 bridged with IABP. Tissues from patients who were bridged without MCS were used as HF tissues.
Frontiers in Cardiovascular Medicine
FEBRUARY 19, 2024
Background Pompe disease (PD) is a rare, progressive autosomal recessive lysosomal storage disorder that directly impacts mitochondrial function, leading to structural abnormalities and potentially culminating in heart failure or cardiogenic shock.
Frontiers in Cardiovascular Medicine
MAY 2, 2024
The cornerstone of treatment is corticosteroids, comprehensive therapy and heart failure management (including advanced mechanical support for fulminant myocarditis). We have described the case of a 17-year-old heart transplant recipient who presented with a cardiogenic shock.
Journal of the American Heart Association
DECEMBER 20, 2024
BackgroundCardiogenic shock complicating acute myocardial infarction is associated with a high mortality rate. Cardiogenic shock after outofhospital cardiac arrest (OHCA) can be due to transient myocardial stunning but also reflect the increasing severity of ongoing heart failure.
Stroke Journal
JANUARY 30, 2025
Primary outcome was ischemic stroke, while secondary outcomes were all-cause mortality, heart failure, cardiogenic shock, MACE (composite of all-cause mortality, heart failure, and ischemic stroke), and acute kidney injury (AKI).Result:After 0.89), P<0.001), and after 1 year (RR, 0.91 (95% CI: 0.86-0.96),
Frontiers in Cardiovascular Medicine
MARCH 10, 2024
2.17), heart failure (pooled RR 1.56, 95% CI: 1.37–1.77), 1.77), cardiogenic shock (pooled RR 3.68, 95% CI 2.65–5.11), HbA1c showed substantial association with long-term mortality (HR 1.69, 95% CI: 1.31–2.18)) 2.18)) with a pooled RR of 1.58 (95% CI 1.26–1.97).
European Journal of Heart Failure
JANUARY 14, 2025
PMR patients were more likely to present in cardiogenic shock (91% vs. 51%, p =0.001), require mechanical circulatory support (74% vs. 34%, p =0.01), and had a higher EuroSCORE II (2313% vs. 1311%, p =0.011). Aetiology of MR, cardiogenic shock, and procedure timing significantly impacted in-hospital mortality.
DAIC
FEBRUARY 29, 2024
ET Murphy Ballroom 4 Comparison of an "Inclisiran First" Strategy with Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes Once-weekly Semaglutide in Patients with Heart Failure With Preserved Ejection Fraction, (..)
103 
Dr. Smith's ECG Blog
NOVEMBER 19, 2016
Authors' commentary: Cardiogenic shock in the setting of severe aortic stenosis. This patient’s severe aortic stenosis (AS) and associated severe cardiogenic shock likely created the ECG pattern, resulting in a very difficult challenge for our inpatient team. If you can use Doppler, then you can diagnose it.
40
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content